Cognitive Stimulation: Dr Gary Cheung of University of Auckland provides a primer on CST, training at UCL, and takeaways from AAIC 2024

Episode 14 • August 28, 2024 • 00:31:29
Cognitive Stimulation: Dr Gary Cheung of University of Auckland provides a primer on CST, training at UCL, and takeaways from AAIC 2024
The Dementia Research Project
Cognitive Stimulation: Dr Gary Cheung of University of Auckland provides a primer on CST, training at UCL, and takeaways from AAIC 2024

Aug 28 2024 | 00:31:29

/

Show Notes

Dr Gary Cheung is an Associate Professor in Psychiatry at the University of Auckland. He conducts research in the field of old age psychiatry and has been instrumental in introducing to New Zealand- cognitive stimulation therapy (CST), an evidence based non-pharmacological intervention for dementia.

You can reach out to Dr. Gary via email [email protected]. Check out the resources mentioned in the podcast conversation; International CST Centre at UCL, St Louis University CST Learning Module

Stay tuned for more dementia related explorations, breakdowns and interviews- please follow the Dementia Research Project wherever you listen to podcasts!

Other Episodes

Episode 7

June 25, 2024 • 00:34:22
Episode Cover

Laughter Therapy: Lotte Mikkelson, CEO of UnitedMind discusses the transformative impact of alternative therapies, neuroplasticity and not taking life too seriously!

Lotte Mikkelsen is a Laughter Yoga expert who has been running her own Laughter Yoga business since the early 2000's while living in Denmark....

Listen

Episode 12

August 28, 2024 • 00:25:23
Episode Cover

Cultural Relevance: Pelden Chejor shares about research into care for older immigrants in Australia, growing up in Bhutan, and dementia research challenges

Pelden Chejor is a public health professional and PhD candidate at Edith Cowan University. His research seeks to explore and analyze the experiences of...

Listen

Episode 4

November 21, 2025 • 00:30:32
Episode Cover

Blood Diagnostics: Mike Banville, CEO of ALZPath on early dementia detection, accessibility and innovation of blood tests

Mike Banville is CEO of ALZpath; a company on a mission to change how we detect Alzheimer’s, earlier and more accessibly. With a career...

Listen